NASDAQ:YDES | Free Cash Flow | YD Bio Ltd

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$6.6M$1.44M-$8.04M
2024-12-31-$1.22M$74,914.00-$1.3M
2023-12-31-$55,657.00$290.00-$55,947.00-412.59%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.